Clover Biopharmaceuticals, Ltd. (2197.HK) HKSE
1.83
+0(+0.00%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.83
+0(+0.00%)
Currency In HKD
| Market Cap | 2.65B |
| Enterprise Value | 2.39B |
| P/E Ratio | -9.98 |
| PEG Ratio | -0.13 |
| Price/Sales Ratio | 585.66 |
| Price/Book Ratio | -1.11 |
| Enterprise/Revenue | 511.13 |
| Enterprise/EBITDA | -8.09 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -57.07 |
| Operating Margin | -71.02 |
| Return On Assets | -0.44 |
| Return On Equity | 0.11 |
| Revenue | 3.41M |
| Revenue/Share | 0 |
| Gross Profit | -23.85M |
| EBITDA | -221.24M |
| Net Income | -199.78M |
| Diluted EPS | -0.16 |
| Total Cash | 286.15M |
| Total Cash/Share | 0.23 |
| Total Debt | 10.62M |
| Total Debt/Equity | -0.01 |
| Current Ratio | 0.19 |
| Book Value Per Share | -1.43 |
| 52-Week Change | 713.33 |
| 52-Week High | 3.2 |
| 52-Week Low | 0.22 |
| Moving Average 50 Days | 2.74 |
| Moving Average 200 Days | 2.34 |
| Average Volume | 6.02M |
| Shares Outstanding | 1.3B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |